Peptide News

Posters
Celebrating 20th Anniversary

Get GenScript’s New Poster

T cell immunotherapies have achieved long term responses in hematological malignancies and promise similar success as solutions for solid tumors through their continued improved design. While conventionally T cell living drugs, such as CAR T cells, have been manufactured through viral methods, new non-viral approaches are opening the door to more effective and safer immunotherapies.

GenScript’s new poster provides an overview of the CAR and TCR T manufacturing workflow, comparing the pros and cons of viral and non-viral T cell engineering approaches.

Advancing to Non-Viral T cell Immunotherapies
Get Free Copy
Please enter a valid first name.
Please enter a valid last name.
Please enter a valid job title.
Please enter a valid institution.
Please enter a valid email address.
Please select a valid country.
Please enter a valid State.
Please enter a city/province.
Please enter a valid posta code.
Are you working with CRISPR-based T cell engineering projects?

GenScript is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Get a closer view of T cell immunotherapy manufacture:

  • Explore alternative T cell immunotherapy manufacturing workflows
  • Learn about the advantages and disadvantages of viral vs. non-viral T cell modifications
  • Find how synthetic DNA HDR templates are revolutionizing and streamlining workflows
  • Discover the many advantages of using long ssDNA knockin HDR templates